TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections.

Johann Motsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.